Clinical trial
Effects of Esketamine on Oxygenation and Quality of Recovery in Patients Undergoing Thoracoscopic Surgery
NCT06822088 is registered in ClinicalTrials.gov with Jinqiao Qian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Esketamine on Oxygenation and Quality of Recovery in Patients Undergoing Thoracoscopic Surgery
- Lead sponsor
- Jinqiao Qian
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- March 1, 2025
- Completion date
- March 20, 2026
- Enrollment
- 126 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esketamine, one-lung ventilation, oxygenation indices